Concurrent 4B: Abstract Session - Research on gender, health inequities, infectious disease, and harm reduction
Tracks
Track 2
| Thursday, October 16, 2025 |
| 2:00 PM - 3:30 PM |
| Hall B |
Speaker
Dr. Catherine Chappell
Associate Professor
University Of Pittsburgh
Miss Grace Burton-Mckeich
Phd Student
Unsw / The Kirby Institute
HEALTHCARE PROVIDER PERSPECTIVES ON MANAGING HEPATITIS C TREATMENT DURING PREGNANCY: CURRENT PRACTICES AND PATHWAYS FORWARD
2:15 PM - 2:30 PMBiography
Grace Burton-McKeich is a PhD candidate and research assistant at the Kirby Institute, UNSW, Sydney. She has an honours degree in Health Sciences from the University of Auckland. In her career she is driven to reduce negative outcomes caused by infectious diseases among vulnerable populations.
Dr. Madeline McCrary
Assistant Professor Of Medicine
Washington University School Of Medicine
Hepatitis C treatment in pregnancy: implementation of a shared decision-making care model
2:30 PM - 2:45 PMBiography
Dr. Madeline McCrary is an infectious diseases and addiction medicine physician and Assistant Professor at the Washington University School of Medicine in St. Louis, MO USA. She is interested in the clinical care of patients who use drugs and innovative models improving access to Hepatitis C treatment including in pregnancy.
Dr Joseph Gregory Rosen
Assistant Professor (Research)
Brown University Warren Alpert Medical School
ADAPTING AND TAILORING OPIOID AGONIST TREATMENT SERVICES FOR FEMALE SEX WORKERS LIVING WITH HIV IN SOUTH AFRICA: AN IMPLEMENTATION PLANNING STUDY
2:45 PM - 3:00 PMBiography
Dr. Joseph "Greg" Rosen is an Assistant Professor of Medicine and Epidemiology (Research) at Brown University and a Research Scientist at Rhode Island Hospital. His research harnesses workforce capacity-enhancement strategies and health system reconfigurations to optimize delivery of HIV and substance use services to marginalized populations globally.
Ms Tamara Barnett
Hepatitis C Nurse Coordinator
Cool Aid Community Health Centre
A GLOBAL PRESPECTIVE ON WOMEN AND HIV PREVENTION MEDICATION: A SCOPING REVIEW OF WOMEN’S PRESPECTIVES AND ENGAGEMENT ACROSS THE CONTINUM
3:00 PM - 3:05 PMBiography
Hepatitis C Program Coordinator of Cool Aid Community Health Centre's Nurse-led Program, Victoria, British Columbia, Canada. York University Masters of Science in Nursing, Toronto, Ontario, Canada.
Dr Ash Stewart
Researcher
Burnet Institute
THE EFFECT OF SEX ON THE INCIDENCE OF AMBULANCE ATTENDANCES AMONG PEOPLE WHO INJECT DRUGS IN VICTORIA, AUSTRALIA
3:05 PM - 3:10 PMBiography
Ash is a post-doctoral researcher at the Burnet in Melbourne, Australia. She works primarily in infectious diseases and research related to the health outcomes and drug-related harms experienced by people who inject drugs. Her pronouns are she/her.
Ms. Hannah Manley
Study Coordinator
Albert Einstein College Of Medicine
GENDER DIFFERENCES IN TRANSACTIONAL SEX AMONG WOMEN AND MEN WHO INJECT DRUGS IN KENYA
3:10 PM - 3:15 PMBiography
Hannah Manley, MA is a Study Coordinator at Albert Einstein College of Medicine in New York. She coordinates work aimed at informing a targeted public health strategy to prevent HIV and other blood borne infection transmission among PWID in Kenya. Previously she has worked on suicide risk and prevention research.
Mr Joshua Dawe
PhD Researcher
University of Bristol
THE RISKS OF HCV AND HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS WHO ALSO UNDERTAKE SEX WORK OR MALE-WITH-MALE SEXUAL ACTIVITY: A META-ANALYSIS COMBINING PUBLISHED AND UNPUBLISHED ESTIMATES
3:15 PM - 3:20 PMBiography
I am a third year PhD candidate at the University of Bristol, with interests in epidemiology and infectious disease modelling. I am a passionate advocate for the rights and health of people who experience disproportionately higher risk of blood-borne virus acquisition.
Dr. Matthew Akiyama
Associate Professor of Medicine
Albert Einstein College of Medicine
DECREASING HIV PREVALENCE AND HCV COMMUNITY VIRAL LOAD AMONG PEOPLE WHO INJECT DRUGS IN KENYA AMIDST SCALE UP OF HARM REDUCTION AND ANTIVIRAL THERAPY, BUT REGIONAL AND GENDER DISPARITIES PERSIST
3:20 PM - 3:25 PMBiography
Dr. Akiyama is an Associate Professor at Albert Einstein College of Medicine. In addition to providing care to people with HIV and HCV, Dr. Akiyama conducts research focusing on marginalized populations with emphasis on the intersection of HIV and HCV among people who use drugs and the criminal legal system.
INHSU 2025
Questions & Discussion
3:25 PM - 3:30 PMBiography
Chairperson
Rita Gatonye
Director
Women In Response To HIV/AIDS and Drug Addiction (WRADA)
Jennifer Havens
Professor
University Of Kentucky
